Although some significant biomarkers were identified in previous studies, including VHL, PBRM1, and BAP1 (16), the mutation of von Hippel–Lindau (VHL), which is a tumor suppressor gene, has played a significant role in the tumorigenesis of ccRCC (16, 17). This evidence concerns the gene BAP1 and nonpapillary renal cell carcinoma.